Meeting
2023 ASCO Breakthrough
The effect of corticosteroid on immunogenicity of SARS-CoV-2 vaccines in solid cancer patients.
Authors
Chayanee Samdaengpan
Chualabhorn Hospital, Bangkok, Thailand
Chayanee Samdaengpan , Prakongboon Sungkasubun , Worawit Chaiwiriyawong , Jomtana Siripaibun , Chumut Phanthunane , Walaipan Tantiyavarong , Wisut Lamlertthon , Teerapat Ungtrakul , Kriangkrai Tawinprai , Piyarat Limpawittayakul
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Gastrointestinal Cancer,Gynecologic Cancer,Head and Neck Cancer,Quality of Care,Genetics/Genomics/Multiomics,Healthcare Equity and Access to Care,Healthtech Innovations,Models of Care and Care Delivery,Population Health,Viral-Mediated Malignancies
Sub Track
Vaccines
Clinical Trial Registration Number
TCTR20221001004
Citation
JCO Global Oncology 9, 2023 (suppl 1; abstr 127)
DOI
10.1200/GO.2023.9.Supplement_1.127
Abstract #
127
Poster Bd #
H3
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Immunogenicity after COVID-19 vaccination in patients with solid tumor and hospital staff: A prospective single-center observational study.
First Author: Yuki Katsuya
Poster
2023 ASCO Genitourinary Cancers Symposium
COVID-19 vaccines in patients with urothelial cancers receiving immune checkpoint inhibitors.
First Author: Danielle Gilbert
Poster
2023 ASCO Genitourinary Cancers Symposium
Clinical characteristics and outcomes of SARS-CoV-2 infection in patients with genitourinary cancer.
First Author: Dorothy Kenny
Poster
2022 ASCO Annual Meeting
Longitudinal immunological responses of COVID-19 vaccination in patients with solid tumors on active treatment: A pilot study.
First Author: Lifen Cao